NCT03157167 2025-03-05An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)Navidea BiopharmaceuticalsPhase 1 Completed15 enrolled 12 charts
NCT00454181 2011-09-16Treatment of Oral Warts in HIV+ PatientsAinos, Inc. (f/k/a Amarillo Biosciences Inc.Phase 2 Completed59 enrolled 13 charts